IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ImageneBio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.00−0.04 (-0.99%)
Close on Oct 19, 2026
- Market cap
- $64.65M
- P/E (TTM)
- –
- Dividend yield
- –
ImageneBio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | ImageneBio | Industry median |
|---|---|---|
| Market Cap | $45.41M | $164.85M |
| Enterprise Value | -$90.79M | $87.06M |
| PB Ratio | 0.32 | 2.03 |
| P/TBV Ratio | 0.32 | 2.31 |
Income (trailing twelve months)
| Measure | ImageneBio | Industry median |
|---|---|---|
| Operating Income | -$58.96M | -$21.44M |
| Pretax Income | -$52.81M | -$14.45M |
| Net Income | -$52.48M | -$22.46M |
| EBITDA | -$58.57M | -$16.91M |
Returns
| Measure | ImageneBio | Industry median |
|---|---|---|
| Return on Assets (ROA) | -37.7% | -41.0% |
| Return on Capital Employed (ROCE) | -40.5% | -37.8% |
Growth
| Measure | ImageneBio | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -62.9% | 2.25% |
| Revenue Growth (5Y CAGR) | -38.6% | 6.42% |
Balance sheet
| Measure | ImageneBio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $136.20M | $62.42M |
| Net Cash (Debt) | $136.20M | $15.68M |
| Net Cash Per Share | $12.00 | $0.66 |
| Equity (Book Value) | $142.07M | $48.79M |
| Book Value Per Share | $12.52 | $1.36 |
| Tangible Book Value | $142.07M | $23.06M |
| Working Capital | $134.54M | $75.77M |
Financial position
| Measure | ImageneBio | Industry median |
|---|---|---|
| Current Ratio | 21.47 | 3.30 |
| Quick Ratio | 20.72 | 2.39 |
Cash flow (trailing twelve months)
| Measure | ImageneBio | Industry median |
|---|---|---|
| Operating Cash Flow | -$52.59M | -$12.35M |
Efficiency
| Measure | ImageneBio | Industry median |
|---|---|---|
| Profits Per Employee | -$3.50M | -$703.34K |
| Employee Count | 15 | 74 |
Dividends and yields
| Measure | ImageneBio | Industry median |
|---|---|---|
| Earnings Yield | -115.6% | -22.7% |
Shares
| Measure | ImageneBio | Industry median |
|---|---|---|
| Shares Outstanding | 11,351,500 | 58,179,650 |
| Shares Change (YoY) | -56.6% | 11.1% |
| Float | 5,345,380 | 49,173,100 |
| Shares Held by Insiders | 52.9% | 11.6% |
| Shares Held by Institutions | 54.9% | 59.4% |
Taxes
| Measure | ImageneBio | Industry median |
|---|---|---|
| Income Tax | -$324.00K | $91.50K |
Scores
| Measure | ImageneBio | Industry median |
|---|---|---|
| Altman Z-Score | 0.20 | -0.24 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from ImageneBio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.